Tumor response and the quality of life after isolated hypoxic pelvic perfusion for advanced G3 cervical cancer: A case series

INTRODUCTION: We present a case series of three patients with advanced cervical cancer who either refused the standard of care systemic or chemoradiation treatment or did not benefit from it. METHODS: We treated patients with isolated hypoxic pelvic perfusion (HPP). RESULTS: Two patients achieved co...

Descripción completa

Detalles Bibliográficos
Autores principales: Aigner, Karl R., Lavinski, Youri, Gailhofer, Sabine
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2020
Materias:
Case Series
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7724000/
https://www.ncbi.nlm.nih.gov/pubmed/33395903
http://dx.doi.org/10.1016/j.ijscr.2020.11.050
Descripción
Sumario:INTRODUCTION: We present a case series of three patients with advanced cervical cancer who either refused the standard of care systemic or chemoradiation treatment or did not benefit from it. METHODS: We treated patients with isolated hypoxic pelvic perfusion (HPP). RESULTS: Two patients achieved complete clinicopathologic response and one patient required surgical excision of the necrotic residual mass containing no viable cancer cells. There were no long-term systemic or local side effects. All patients are cancer free for up to 15 years after conclusion of treatment. CONCLUSION: HPP is an effective option for treatment of advanced cervical cancer that generates rapid and onlasting remissions at low side effects. Gynecologic oncologists shall be aware of HPP to facilitate wider adaption of our technique.

Ejemplares similares